These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33067577)

  • 21. Inhibition of Ras-mediated signaling pathways in CML stem cells.
    Bertacchini J; Ketabchi N; Mediani L; Capitani S; Marmiroli S; Saki N
    Cell Oncol (Dordr); 2015 Dec; 38(6):407-18. PubMed ID: 26458816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic myeloid leukemia stem cells and developing therapies.
    Donato NJ; Peterson LF
    Leuk Lymphoma; 2011 Feb; 52 Suppl 1():60-80. PubMed ID: 21299460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.
    Weisberg E; Banerji L; Wright RD; Barrett R; Ray A; Moreno D; Catley L; Jiang J; Hall-Meyers E; Sauveur-Michel M; Stone R; Galinsky I; Fox E; Kung AL; Griffin JD
    Blood; 2008 Apr; 111(7):3723-34. PubMed ID: 18184863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance: key role of stromal microenvironment.
    Seke Etet PF; Vecchio L; Nwabo Kamdje AH
    Cell Signal; 2012 Sep; 24(9):1883-8. PubMed ID: 22659137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic myeloid leukemia stem cells require cell-autonomous pleiotrophin signaling.
    Himburg HA; Roos M; Fang T; Zhang Y; Termini CM; Schlussel L; Kim M; Pang A; Kan J; Zhao L; Suh H; Sasine JP; Sapparapu G; Bowers PM; Schiller G; Chute JP
    J Clin Invest; 2020 Jan; 130(1):315-328. PubMed ID: 31613796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of key candidate targets and pathways for the targeted treatment of leukemia stem cells of chronic myelogenous leukemia using bioinformatics analysis.
    Li H; Liu L; Zhuang J; Liu C; Zhou C; Yang J; Gao C; Liu G; Sun C
    Mol Genet Genomic Med; 2019 Sep; 7(9):e851. PubMed ID: 31373443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hedgehog pathway activation in chronic myeloid leukemia.
    Jagani Z; Dorsch M; Warmuth M
    Cell Cycle; 2010 Sep; 9(17):3449-56. PubMed ID: 20928937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.
    Cheloni G; Tanturli M; Tusa I; Ho DeSouza N; Shan Y; Gozzini A; Mazurier F; Rovida E; Li S; Dello Sbarba P
    Blood; 2017 Aug; 130(5):655-665. PubMed ID: 28576876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic myeloid leukemia stem cells.
    Kavalerchik E; Goff D; Jamieson CH
    J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular biology of chronic myeloid leukemia.
    Maru Y
    Int J Hematol; 2001 Apr; 73(3):308-22. PubMed ID: 11345196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells.
    Abraham SA; Hopcroft LE; Carrick E; Drotar ME; Dunn K; Williamson AJ; Korfi K; Baquero P; Park LE; Scott MT; Pellicano F; Pierce A; Copland M; Nourse C; Grimmond SM; Vetrie D; Whetton AD; Holyoake TL
    Nature; 2016 Jun; 534(7607):341-6. PubMed ID: 27281222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells.
    Reddiconto G; Toto C; Palamà I; De Leo S; de Luca E; De Matteis S; Dini L; Passerini CG; Di Renzo N; Maffia M; Coluccia AM
    Blood; 2012 Mar; 119(10):2335-45. PubMed ID: 22262776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia.
    Chorzalska A; Kim JF; Roder K; Tepper A; Ahsan N; Rao RSP; Olszewski AJ; Yu X; Terentyev D; Morgan J; Treaba DO; Zhao TC; Liang O; Gruppuso PA; Dubielecka PM
    Stem Cells Dev; 2017 May; 26(9):656-677. PubMed ID: 28103766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anthelmintic drug niclosamide enhances the sensitivity of chronic myeloid leukemia cells to dasatinib through inhibiting Erk/Mnk1/eIF4E pathway.
    Liu Z; Li Y; Lv C; Wang L; Song H
    Biochem Biophys Res Commun; 2016 Sep; 478(2):893-9. PubMed ID: 27520370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.
    Mukherjee K; Sha X; Magimaidas A; Maifrede S; Skorski T; Bhatia R; Hoffman B; Liebermann DA
    Oncotarget; 2017 Feb; 8(7):10809-10821. PubMed ID: 28086219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1.
    Wang Z; Chen CC; Chen W
    Stem Cells; 2015 Dec; 33(12):3437-51. PubMed ID: 26466808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective and effective targeting of chronic myeloid leukemia stem cells by topoisomerase II inhibitor etoposide in combination with imatinib mesylate in vitro.
    Liu MY; Wang WZ; Liao FF; Wu QQ; Lin XH; Chen YH; Cheng L; Jin XB; Zhu JY
    Cell Biol Int; 2017 Jan; 41(1):16-23. PubMed ID: 27677634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemia stem cells: the root of chronic myeloid leukemia.
    Zhou H; Xu R
    Protein Cell; 2015 Jun; 6(6):403-12. PubMed ID: 25749979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The one-two punch: combination treatment in chronic myeloid leukemia.
    Sweet KL; Hazlehurst LA; Pinilla-Ibarz J
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):667-79. PubMed ID: 23969231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.
    Prost S; Relouzat F; Spentchian M; Ouzegdouh Y; Saliba J; Massonnet G; Beressi JP; Verhoeyen E; Raggueneau V; Maneglier B; Castaigne S; Chomienne C; Chrétien S; Rousselot P; Leboulch P
    Nature; 2015 Sep; 525(7569):380-3. PubMed ID: 26331539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.